Evidence map›Paper›PMID 38201855›Full record

ArticleNutrients2023

The Mechanism Underlying the Hypoglycemic Effect of Epimedin C on Mice with Type 2 Diabetes Mellitus Based on Proteomic Analysis.

Xuexue Zhou, Ziqi Liu, Xiaohua Yang, Jing Feng, Murat Sabirovich Gins, Tingyu Yan, Lei Han, Huafeng Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Exploring the mechanism ofCytotechnology · 2025
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Xuexue ZhouNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Academician and Expert Workstations in Puer City of Yunnan Province, College of Food Engineering and Nutritional Science, Provincial Research Station of Se-Enriched Foods in Hanyin County of Shaanxi Province, International Joint Research Center of Shaanxi Province for Food and Health Sciences, Shaanxi Normal University, Xi'an 710119, China.
Ziqi LiuNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Academician and Expert Workstations in Puer City of Yunnan Province, College of Food Engineering and Nutritional Science, Provincial Research Station of Se-Enriched Foods in Hanyin County of Shaanxi Province, International Joint Research Center of Shaanxi Province for Food and Health Sciences, Shaanxi Normal University, Xi'an 710119, China.
Xiaohua YangResearch Station of Selenium-Enriched Tea of Shaanxi Province, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China.
Jing FengNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Academician and Expert Workstations in Puer City of Yunnan Province, College of Food Engineering and Nutritional Science, Provincial Research Station of Se-Enriched Foods in Hanyin County of Shaanxi Province, International Joint Research Center of Shaanxi Province for Food and Health Sciences, Shaanxi Normal University, Xi'an 710119, China.
Murat Sabirovich GinsAgrarian and Technological Institute, Peoples' Friendship University of Russia, Moscow 119991, Russia.ORCID 0000-0001-5995-2696
Tingyu YanNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Academician and Expert Workstations in Puer City of Yunnan Province, College of Food Engineering and Nutritional Science, Provincial Research Station of Se-Enriched Foods in Hanyin County of Shaanxi Province, International Joint Research Center of Shaanxi Province for Food and Health Sciences, Shaanxi Normal University, Xi'an 710119, China.
Lei HanNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Academician and Expert Workstations in Puer City of Yunnan Province, College of Food Engineering and Nutritional Science, Provincial Research Station of Se-Enriched Foods in Hanyin County of Shaanxi Province, International Joint Research Center of Shaanxi Province for Food and Health Sciences, Shaanxi Normal University, Xi'an 710119, China.
Huafeng ZhangNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Academician and Expert Workstations in Puer City of Yunnan Province, College of Food Engineering and Nutritional Science, Provincial Research Station of Se-Enriched Foods in Hanyin County of Shaanxi Province, International Joint Research Center of Shaanxi Province for Food and Health Sciences, Shaanxi Normal University, Xi'an 710119, China.ORCID 0000-0001-5745-1783
Shaanxi Normal University · CNPeoples' Friendship University of Russia · RUXi'an Jiaotong University · CN

Funding

Key Research and Development Program of Shaanxi Province and Ankang City (Key Laboratory of Se-enriched Products Development and Quality Control of Ministry of Agriculture and Rural Affairs and National-Local Joint Engineering Laboratory of Se-enriched Fo 2022ZDLSF05-11/Se-2023C04National Program of Belt and Road Innovative Talents Exchange of the Chinese Ministry of Science and Technology DL2023173001LProgram of Academician and Expert Workstation in Puer City of Yunnan Province in China 202305AF150118
6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) has become a worldwide public health problem. Epimedin C is considered one of the most important flavonoids in

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsCholesterolFlavonoidsHumansInsulinPhosphoenolpyruvate Carboxykinase (ATP)ProteomicsCholesterolepimedin CFlavonoidsHypoglycemic AgentsInsulinPhosphoenolpyruvate Carboxykinase (ATP)epimedin Clabel-free proteomic techniquemechanism of actionmicetype 2 diabetes mellitus

Identifiers

PMID38201855
PMCPMC10780735
OpenAlexW4390058144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.